Conferences Vaccinex is attending in 2026–2027

LinkedIn

Vaccinex is listed at 2 conferences on Tnuki's calendar in 2026–2027: PEGS Boston 2027 (exhibiting) and Discovery on Target 2026 (exhibiting). Vaccinex develops monoclonal antibody therapeutics for cancer and neurodegenerative diseases. As of Sep 29, 2026.

ConferenceDetailsInvolvementTnuki guide
PEGS Boston 2027 — Protein & Antibody Engineering SummitProtein & antibody engineersOfficial site
Boston, MA ~2.4k attendees ExhibitingCambridge Innovation Institute publishes no sponsorship level for this eventTalks and attendees: not yet availableAttendee mix: Mostly biopharma; protein and antibody engineers, biologics developers and discovery group leaders Guide coming soon
Discovery on Target 2026Target discovery biologists & chemistsOfficial site
Past Boston, MA ~1.1k attendees ExhibitingCambridge Healthtech Institute publishes no sponsorship level for this eventTalks and attendees: not yet availableAttendee mix: Mostly biopharma; target discovery biologists, medicinal chemists and discovery group leaders, some academics Guide coming soon

We hold published exhibitor, sponsor, program or attendee lists for 29 of the 90 conferences on our calendar, so this page shows Vaccinex’s involvement at those 29 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Vaccinex

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →